1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Dysplasia: new trials by email Literature Review of Dysplasia trials Research Report on Dysplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Pharmacological Study - Dysplasia, Metaplasia | Phase 1 | Terminated | National Cancer Institute (NCI) | 60 | 2009-10-01 | 2015-02-18 |
Metaplasia (1)
Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
National Cancer Institute (NCI) (1)
United States (1)
Seema Khan (1)
N01CN35157 (1), P30CA060553 (1)